Applying diagnosis and pharmacy-based risk models to predict pharmacy use in Aragon, Spain: the impact of a local calibration

Published: January 21, 2010
Category: Bibliography > Papers
Authors: Abrams C, Calderon-Larranaga A, Poblador-Plou B, Prados-Torres A, Weiner JP
Countries: Spain
Language: null
Types: Care Management
Settings: Government, Hospital

BMC Health Serv Res 10:22.

Aragon Health Science Institute, Zaragoza, Spain

BACKGROUND: In the financing of a national health system, where pharmaceutical spending is one of the main cost containment targets, predicting pharmacy costs for individuals and populations is essential for budget planning and care management. Although most efforts have focused on risk adjustment applying diagnostic data, the reliability of this information source has been questioned in the primary care setting. We sought to assess the usefulness of incorporating pharmacy data into claims-based predictive models (PMs). Developed primarily for the U.S. health care setting, a secondary objective was to evaluate the benefit of a local calibration in order to adapt the PMs to the Spanish health care system.

METHODS: The population was drawn from patients within the primary care setting of Aragon, Spain (n = 84,152). Diagnostic, medication and prior cost data were used to develop PMs based on the Johns Hopkins ACG methodology. Model performance was assessed through r-squared statistics and predictive ratios. The capacity to identify future high-cost patients was examined through c-statistic, sensitivity and specificity parameters.

RESULTS: The PMs based on pharmacy data had a higher capacity to predict future pharmacy expenses and to identify potential high-cost patients than the models based on diagnostic data alone and a capacity almost as high as that of the combined diagnosis-pharmacy-based PM. PMs provided considerably better predictions when calibrated to Spanish data.

CONCLUSION: Understandably, pharmacy spending is more predictable using pharmacy-based risk markers compared with diagnosis-based risk markers. Pharmacy-based PMs can assist plan administrators and medical directors in planning the health budget and identifying high-cost-risk patients amenable to care management programs.

PMID: 20092654
PMCID: PMC2828433

Care Management,Cost Burden Evaluation,Predictive Risk Modeling,Spain,Electronic Health Records,Gender,Linear Models,Logistic Models,Models,Econometric,National Health Programs/economics,Pharmaceutical Services/economics,ROC Curve,Risk Adjustment,Risk Factors,United States

Please log in/register to access.

Log in/Register

LinkedIn Facebook Twitter

© The Johns Hopkins University, The Johns Hopkins Hospital, and Johns Hopkins Health System.
All rights reserved. Terms of Use Privacy Statement

Back to top